Vertex Pharma (VRTX) June volatility elevated into data

Vertex Pharma (Nasdaq: VRTX) PDUFA date for Incivek, (hepatitis C virus treatment) is expected on May 23. May put option implied volatility is at 62, June is at 56, July at 49; compared to its six-month average of 42 according to Track Data.

---

Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!